Flavin-dependent antioxidant properties of a new series of meso-N,N′-dialkyl-imidazolium substituted manganese(III) porphyrins

Biochemical Pharmacology

Volumn 67, Issue 1, 2004, Pages 77-85

  Kachadourian, Remy ^a   Johnson, Chris A ^a   Min, Elysia ^a   Spasojevic, Ivan ^b   Day, Brian J ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Diaphorase; Diphenyleneiodonium; F2 isoprostanes; Lipid peroxidation; Metalloporphyrins; TBARS

Indexed keywords

ASCORBIC ACID; CATALASE; IMIDAZOLE DERIVATIVE; IRON; ISOPROSTANE DERIVATIVE; LIPID; MANGANESE DERIVATIVE; OXIDOREDUCTASE; PORPHYRIN DERIVATIVE; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; TETRAKIS(N,N' DIMETHYLIMIDAZOLIUM 2 YL)PORPHYRIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CATALYSIS; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; IC 50; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

EID: 0344255591     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.08.036     Document Type: Article

References (49)

1. Riley D.P. Functional mimics of superoxide dismutase enzymes as therapeutic agents. Chem. Rev. 99(9):1999;2573-2588.
2. Day B.J., Fridovich I., Crapo J.D. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch. Biochem. Biophys. 347(2):1997;256-262.
3. Day B.J., Batinic-Haberle I., Crapo J.D. Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic. Biol. Med. 26(5/6):1999;730-736.
4. Szabo C., Day B.J., Salzman A.L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett. 381(1-2):1996;82-86.
5. Hunt J.A., Lee J., Groves J.T. Amphiphilic peroxynitrite decomposition catalysts in liposomal assemblies. Chem. Biol. 4(11):1997;845-858.
6. Ferrer-Sueta G., Batinic-Haberle I., Spasojevic I., Fridovich I., Radi R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N- methylpyridylporphyrins in the presence of reductants. Chem. Res. Toxicol. 12(5):1999;442-449.
7. Patel M., Day B.J., Crapo J.D., Fridovich I., McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron. 16(2):1996;345-355.
8. Day B.J., Shawen S., Liochev S.I., Crapo J.D. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro. J. Pharmacol. Exp. Ther. 275(3):1995;1227-1232.
9. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18(2):1998;159-163.
10. Mackensen G.B., Patel M., Sheng H., Calvi C.L., Batinic-Haberle I., Day B.J., Liang L.P., Fridovich I., Crapo J.D., Pearlstein R.D., Warner D.S. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J. Neurosci. 21(13):2001;4582-4592.
11. Piganelli J.D., Flores S.C., Cruz C., Koepp J., Batinic-Haberle I., Crapo J., Day B., Kachadourian R., Young R., Bradley B., Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes. 51(2):2002;347-355.
12. Batinic-Haberle I., Benov L., Spasojevic I., Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J. Biol. Chem. 273(38):1998;24521-24528.
13. Kachadourian R., Menzeleev R., Agha B., Bocckino S.B., Day B.J. High-performance liquid chromatography with spectrophotometric and electrochemical detection of a series of manganese(III) cationic porphyrins. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 767(1):2002;61-67.
14. - disproportionation. Inorg. Chem. 41(22):2002;5874-5881.
15. Roberts L.J., Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28(4):2000;505-513.
16. Tjahjono D.H., Akutsu T., Yoshioka N., Inoue H. Cationic porphyrins bearing diazolium rings: synthesis and their interaction with calf thymus DNA. Biochim. Biophys. Acta. 1472(1-2):1999;333-343.
17. Kachadourian R., Batinic-Haberle I., Fridovich I. Synthesis and superoxide dismuting activities of partially (1-4) b-chlorinated derivatives of manganese(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin. Inorg. Chem. 38:1999;391-396.
18. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244(22):1969;6049-6055.
19. Del Rio L.A., Ortega M.G., Lopez A.L., Gorge J.L. A more sensitive modification of the catalase assay with the Clark oxygen electrode. Application to the kinetic study of the pea leaf enzyme. Anal. Biochem. 80(2):1977;409-415.
20. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195:1952;133-140.
21. Braughler J.M., Pregenzer J.F., Chase R.L., Duncan L.A., Jacobsen E.J., McCall J.M. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262(22):1987;10438-10440.
22. Bernheim F., Bernheim M.L.C., Wilber K.M. The reaction between thiobarbituric acid and the oxidation products of certain lipids. J. Biol. Chem. 174:1948;257-264.
23. Morrow J.D., Harris T.M., Roberts L.J. II Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184(1):1990;1-10.
24. Bloodsworth A., O'Donnell V.B., Batinic-Haberle I., Chumley P.H., Hurt J.B., Day B.J., Crow J.P., Freeman B.A. Manganese-porphyrin reactions with lipids and lipoproteins. Free Radic. Biol. Med. 28(7):2000;1017-1029.
25. Thibodeau P.A., Kachadourian R., Lemay R., Bisson M., Day B.J., Paquette B. In vitro pro- and antioxidant properties of estrogens. J. Steroid Biochem. Mol. Biol. 81(3):2002;227-236.
26. O'Donnell B.V., Tew D.G., Jones O.T., England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290(Pt 1):1993;41-49.
27. +. J. Biol. Chem. 278(9):2003;6831-6837.
28. Sheng H., Enghild J.J., Bowler R., Patel M., Batinic-Haberle I., Calvi C.L., Day B.J., Pearlstein R.D., Crapo J.D., Warner D.S. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic. Biol. Med. 33(7):2002;947-961.
29. Holderman M.T., Miller K.P., Dangott L.J., Ramos K.S. Identification of albumin precursor protein, Phi AP3, and alpha-smooth muscle actin as novel components of redox sensing machinery in vascular smooth muscle cells. Mol. Pharmacol. 61(5):2002;1174-1183.
30. Lennon A.M., Ramauge M., Pierre M. Role of redox status on the activation of mitogen-activated protein kinase cascades by NSAIDs. Biochem. Pharmacol. 63(2):2002;163-170.
31. Haddad J.J. The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem. Pharmacol. 63(2):2002;305-320.
32. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell Signal. 11(1):1999;1-14.
33. Baker K., Marcus C.B., Huffman K., Kruk H., Malfroy B., Doctrow S.R. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J. Pharmacol. Exp. Ther. 284(1):1998;215-221.
34. Milano J., Day B.J. A catalytic antioxidant metalloporphyrin blocks hydrogen peroxide-induced mitochondrial DNA damage. Nucleic Acids Res. 28(4):2000;968-973.
35. Choudhary S., Keshavarzian A., Yong S., Wade M., Bocckino S., Day B.J., Banan A. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig. Dis. Sci. 46(10):2001;2222-2230.
36. Hoffman S.W., Moore S., Ellis E.F. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 28(4):1997;844-849.
37. Lahaie I., Hardy P., Hou X., Hassessian H., Asselin P., Lachapelle P., Almazan G., Varma D.R., Morrow J.D., Roberts L.J. Jr., Chemtob S. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am. J. Physiol. 274(5 Pt 2):1998;R1406-R1416.
38. Massey V. Activation of molecular oxygen by flavins and flavoproteins. J. Biol. Chem. 269(36):1994;22459-22462.
39. Day B.J., Patel M., Calavetta L., Chang L.Y., Stamler J.S. A mechanism of paraquat toxicity involving nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 96(22):1999;12760-12765.
40. Ganey P.E., Kauffman F.C., Thurman R.G. Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver. Mol. Pharmacol. 34(5):1988;695-701.
41. Kagan V.E., Tyurina Y.Y. Recycling and redox cycling of phenolic antioxidants. Ann. N.Y. Acad. Sci. 854:1998;425-434.
42. Pfeiffer S., Schrammel A., Koesling D., Schmidt K., Mayer B. Molecular actions of a Mn(III)Porphyrin superoxide dismutase mimetic and peroxynitrite scavenger: reaction with nitric oxide and direct inhibition of NO synthase and soluble guanylyl cyclase. Mol. Pharmacol. 53(4):1998;795-800.
43. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273(25):1998;15646-15653.
44. Salvemini D., Riley D.P., Lennon P.J., Wang Z.Q., Currie M.G., Macarthur H., Misko T.P. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br. J. Pharmacol. 127(3):1999;685-692.
45. Cross A.H., San M., Stern M.K., Keeling R.M., Salvemini D., Misko T.P. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 107(1):2000;21-28.
46. Cuzzocrea S., Misko T.P., Costantino G., Mazzon E., Micali A., Caputi A.P., Macarthur H., Macarthur H., Salvemini D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14(9):2000;1061-1072.
47. Naidu B.V., Farivar A.S., Woolley S.M., Fraga C., Salzman A.L., Szabo C., Groves J.T., Mulligan M.S. Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. Exp. Mol. Pathol. 75(1):2003;12-17.
48. Pacher P., Liaudet L., Bai P., Mabley J.G., Kaminski P.M., Virag L., Deb A., Szabo E., Ungvari Z., Wolin M.S., Groves J.T., Szabo C. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation. 107(6):2003;896-904.
49. Szabo C., Mabley J.G., Moeller S.M., Shimanovich R., Pacher P., Virag L., Soriano F.G., Van Duzer J.H., Williams W., Salzman A.L., Groves J.T. Part I: Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 8(10):2002;571-580.